Study Assessing Tolerability and Safety and Exploring the Immunogenicity and Therapeutic Activity of AFFITOPE® PD01A in PD-GBA Patients Study Assessing Tolerability and Safety and Exploring the Immunogenicity and Therapeutic Activity of ...
A Randomized, Placebo-controlled, Parallel Group, Patient-blind, Single-center Phase I Pilot Study Assessing Tolerability and Safety and Exploring the Immunogenicity and Therapeutic Activity of AFFITOPE® PD01A, a New Vaccine Against Alpha-synuclein, in Patients With PD-GBA A Randomized, Placebo-controlled, Parallel Group, Patient-blind, Single-center Phase I Pilot Study A ...